We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

59 hedge funds and large institutions have $170M invested in Foghorn Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $135M → $170M (+$35M)

6% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 17

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.03% less ownership

Funds ownership: 64.32% → 62.29% (-2%)

3% less funds holding

Funds holding: 61 → 59 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
59
Holders Change
-2
Holders Change %
-3.28%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
18
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RJA
Raymond James & Associates
Florida
+$2.77M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.1M
3
Morgan Stanley
Morgan Stanley
New York
+$595K
4
SCM
Sio Capital Management
New York
+$525K
5
PAM
Panagora Asset Management
Massachusetts
+$269K

Top Sellers

1
AG
Artal Group
Luxembourg
-$4.31M
2
DM
Deerfield Management
New York
-$3.89M
3
GW
GW & Wade
Massachusetts
-$539K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$381K
5
BlackRock
BlackRock
New York
-$371K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$9.85K -$14.6K -3,394 -69%
SS
52
Sunbelt Securities
Texas
$9.68K – – –
WT
53
Washington Trust
Rhode Island
$9.68K – – –
CAL
54
Capital Analysts LLC
Pennsylvania
$4K – – –
Group One Trading
55
Group One Trading
Illinois
$3.84K – – –
VAG
56
VisionPoint Advisory Group
Texas
$1.35K – – –
TFM
57
TFC Financial Management
Massachusetts
$794 – – –
Russell Investments Group
58
Russell Investments Group
United Kingdom
$645 +$431 +100 New
Zurich Cantonal Bank
59
Zurich Cantonal Bank
Switzerland
$13 -$10.8K -2,510 -100%
DM
60
Deerfield Management
New York
– -$3.89M -777,525 Closed
GW
61
GW & Wade
Massachusetts
– -$539K -107,770 Closed
IC
62
Ikarian Capital
Texas
– -$76.5K -15,292 Closed
MIM
63
MetLife Investment Management
New Jersey
– -$57.2K -11,445 Closed
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
– -$6.47K -1,295 Closed
CUAMC
65
China Universal Asset Management Company
China
– -$5.37K -1,073 Closed
Osaic Holdings
66
Osaic Holdings
Arizona
– -$1.5K -300 Closed
Daiwa Securities Group
67
Daiwa Securities Group
Japan
– -$1K -168 Closed
1 2
3

FHTX Hedge Fund Activity: Q4 2023 in Review

59 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2023, worth a combined $170M — up 26% from $135M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FHTX and 6 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 18 added.

The largest buyer was Raymond James & Associates, adding an estimated $2.77M. The largest seller was Artal Group, cutting an estimated $4.31M.

  • 59 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2023, down from 61 in Q3 2023.
  • Funds reported $170M of Foghorn Therapeutics stock for Q4 2023, up 26% quarter-over-quarter.
  • 6 funds opened new Foghorn Therapeutics positions in Q4 2023 and 8 closed out, a net change of -2 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2023 was Raymond James & Associates, an estimated $2.77M added.
  • The largest Foghorn Therapeutics seller in Q4 2023 was Artal Group, an estimated $4.31M sold.

Based on aggregated 13F filings for Q4 2023.